Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Can randomized clinical trials impact the surgical approach for hypoplastic left heart syndrome? World journal for pediatric & congenital heart surgery Tabbutt, S., Goldberg, C., Ohye, R. G., Morell, V. O., Hanley, F. L., Lamberti, J. J., Jacobs, M. L., Jacobs, J. P. 2011; 2 (3): 445-456

Abstract

The Eighth International Conference of the Pediatric Cardiac Intensive Care Society was held in Miami, Florida, December 8 to 11, 2010. The program included a session dedicated to the management of hypoplastic left heart syndrome (HLHS), with particular emphasis on the innovations that have led to contemporary schemes of management and the role of clinical trials in the evolution and acceptance of these strategies. An invited panel of experts reviewed the historical evolution of staged surgical reconstruction, the randomized clinical trials that have been undertaken thus far, and the extent to which these have, or have not, influenced individual and institutional approaches to management of HLHS.

View details for DOI 10.1177/2150135111406942

View details for PubMedID 23803996